Zydus Lifesciences Limited — Valsartan Exporter Profile
Indian Pharmaceutical Exporter · #13 for Valsartan · $1.4M export value · DGFT Verified
Zydus Lifesciences Limited is the #13 Indian exporter of Valsartan with $1.4M in export value and 64 verified shipments. Zydus Lifesciences Limited holds a 0.7% market share in Valsartan exports across 7 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Valsartan Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Valsartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $314.7K | 7 | 31.5% |
| SPAIN | $202.3K | 11 | 20.2% |
| FRANCE | $111.0K | 22 | 11.1% |
| SOUTH AFRICA | $101.5K | 12 | 10.2% |
| VIETNAM, DEMOCRATIC REP. OF | $100.0K | 2 | 10.0% |
| PHILIPPINES | $71.9K | 3 | 7.2% |
| VIETNAM | $50.0K | 1 | 5.0% |
| MAURITIUS | $47.8K | 6 | 4.8% |
Zydus Lifesciences Limited exports Valsartan to 8 countries. The largest destination is MEXICO accounting for 31.5% of Zydus Lifesciences Limited's Valsartan shipments, followed by SPAIN (20.2%) and FRANCE (11.1%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Valsartan from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZYDUS PHARMACEUTICALS MEXICO S.A. D | MEXICO | $164.7K | 4 |
| LABORATORIOS COMBIX SLU | SPAIN | $128.2K | 7 |
| ZYDUS HEALTHCARE SA (PTY) LTD | SOUTH AFRICA | $101.5K | 12 |
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $100.0K | 2 |
| ZYDUS PHARMACEUTICALS MXICO S.A. | MEXICO | $50.0K | 1 |
| ZYDUS PHARMACEUTICALS MEXICO S.A.DE | MEXICO | $50.0K | 1 |
| ZYDUS PHARMACEUTICALS M?XICO S.A. D | MEXICO | $50.0K | 1 |
| CAMEL INTERNATIONAL IM-EXPORT CO., | VIETNAM | $50.0K | 1 |
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $47.9K | 6 |
| DSV AIR Y SEA S.A.U. | SPAIN | $45.0K | 2 |
Zydus Lifesciences Limited supplies Valsartan to 20 buyers globally. The largest buyer is ZYDUS PHARMACEUTICALS MEXICO S.A. D (MEXICO), followed by LABORATORIOS COMBIX SLU (SPAIN) and ZYDUS HEALTHCARE SA (PTY) LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Valsartan Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $113.6M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. Zydus Lifesciences Limited contributes $1.4M to this total, accounting for 0.7% of India's Valsartan exports. Zydus Lifesciences Limited ships Valsartan to 8 countries through 20 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Valsartan Exports?
Zydus Lifesciences Limited's average Valsartan shipment value is $21.7K per consignment, based on 64 shipments totaling $1.4M. The largest destination is MEXICO (31.5% of Zydus Lifesciences Limited's Valsartan exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Valsartan Exporters?
Zydus Lifesciences Limited ranks #13 among 259 Indian Valsartan exporters with a 0.7% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($28.9M), MACLEODS PHARMACEUTICALS LTD ($27.9M), ALEMBIC PHARMACEUTICALS LIMITED ($10.5M). Zydus Lifesciences Limited processed 64 shipments to 7 destination countries.
What Valsartan Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VALSARTAN & HCTZ TABLETS 160/12.5 MG (2X | $100.0K | 2 |
| VALAZYD 80MG TAB (VALSARTAN) 10 X 10 TNOS | $100.0K | 2 |
| VALSARTAN COMBIX 160MG TABLETS (VALSARTA | $70.8K | 2 |
| VALSARTAN & HCTZ TABLETS 160/12.5 MG (VA | $64.7K | 2 |
| PHARMA MEDICINE FOR HUMAN USE-VALAZYD 160 TABS 3X10 TABS SOUTH AFRICA (VALSARTAN) QTY-5,258.000 PAC AS PER INVOICE | $52.3K | 3 |
| VALSARTAN & HCTZ TABLETS 160/12.5 MG - 2 | $50.0K | 1 |
| VALSARTAN & HCTZ TABLETS 160/12.5MG (VAL | $50.0K | 1 |
| VALSARTAN & HCTZ TABLETS 160/12.5 MG - 2X7(VALSARTAN & HCTZ TABLETS 160/12.5 MG 2 X 7)B.NO M405674 DETAILS AS PER INV | $50.0K | 1 |
| AMLODAC-VL (AMLODIPINE AND VALSARTAN TABS USP 5 MG/160 MG) 3X10 T | $50.0K | 1 |
| VALAZYD 80MG TAB (VALSARTAN) 10X10 T | $36.0K | 1 |
Zydus Lifesciences Limited exports 42 distinct Valsartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALSARTAN & HCTZ TABLETS 160/12.5 MG (2X with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Valsartan to Key Markets
What Zydus Lifesciences Limited must comply with to export Valsartan to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Lifesciences Limited Compare to Nearest Valsartan Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | HETERO LABS LIMITED | $2.3M | 75 | 18 | $30.6K |
| 12 | TORRENT PHARMACEUTICALS LTD | $1.5M | 65 | 4 | $23.3K |
| 13 | ZYDUS LIFESCIENCES LIMITED ★ | $1.4M | 64 | 7 | $21.7K |
| 14 | DR REDDYS LABORATORIES LIMITED | $1.4M | 30 | 3 | $45.7K |
| 15 | DR REDDY S LABORATORIES LIMITED | $900.0K | 18 | 1 | $50.0K |
Zydus Lifesciences Limited ranks #13 among 259 Indian Valsartan exporters. Average shipment value of $21.7K compared to the market average of $438.5K. The closest competitors by value are HETERO LABS LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Valsartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 946 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 627 | 10.3% |
| DELHI AIR | 516 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 445 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 323 | 5.3% |
| JNPT | 213 | 3.5% |
| MUNDRA SEA | 176 | 2.9% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Valsartan Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Valsartan, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 64 individual customs records matching Zydus Lifesciences Limited exporting Valsartan, covering 42 formulations to 8 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Valsartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Valsartan Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current shipment-level data, contact TransData Nexus.